raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:160

Castleman disease

Synonyms: Angiofollicular ganglionic hyperplasia · Angiofollicular lymph hyperplasia

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare lymphoid hemopathy characterized by involvement of lymph nodes in any part of the body, most frequently the mediastinum, abdomen, neck, or spleen, and occurring as unicentric, idiopathic multicentric, or KSHV/HHV8-associated multicentric Castleman disease. Depending on the type, patients are most commonly asymptomatic or typically present with systemic symptoms.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enCastleman diseaseAngiofollicular ganglionic hyperplasia · Angiofollicular lymph hyperplasia
frMaladie de CastlemanHyperplasie ganglionnaire angiofolliculaire · Hyperplasie lymphoïde angiofolliculaire · Pseudotumeur de Castleman
deCastleman-KrankheitAngiofollikuläre Lymphknotenhyperplasie · Castleman-Lymphom
esEnfermedad de Castleman
itMalattia di CastlemanIperplasia ganglionaria angiofollicolare · Iperplasia linfatica angiofollicolare
nlZiekte van CastlemanAngiofolliculaire ganglionhyperplasie · Angiofolliculaire lymfehyperplasie
ptDoença CastlemanHamartoma linfóide · Hiperplasia ganglionar angiofolicular · Linfoma benigno
plChoroba CastlemanaAngiofollicular ganglionic hyperplasia · Naczyniowogrudkowy przerost węzłów chłonnych
csCastlemanova chorobaAngiofolikulární ganglionická hyperplázie · Angiofolikulární hyperplázie uzlin
ukХвороба КастлеманаАнгіофолікулярна гангліонарна гіперплазія · Ангіофолікулярна лімфатична гіперплазія
zhCastleman病血管滤泡性淋巴增生
trCastleman hastalığıAnjiyofoliküler lenf hiperplazisi · Anjiyofoliküler ganglionik hiperplazi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM148000BTNTvalidated
ICD-10D47.7NTBTindexvalidated
ICD-114B2YNTBTindexvalidated
MONDO0015564Evalidated
MeSHD005871Evalidated
UMLSC0017531Evalidated
GARD12656Evalidated
MedDRA10050251Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (3):

Codes that Orphanet moved or referred to this one:

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET
Annual incidence1-9 / 100 000—United StatesClass onlyValidatedORPHANET_25120049[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

29 annotations · validated 2019-04-30
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002716Lymphadenopathy
Frequent (79-30%)
HP:0002027Abdominal pain
HP:0001903Anemia
HP:0025142Constitutional symptom
HP:0011227Elevated circulating C-reactive protein concentration
HP:0003565Elevated erythrocyte sedimentation rate
HP:0012378Fatigue
HP:0002729Follicular hyperplasia
HP:0030783Increased circulating interleukin 6 concentration
HP:0100721Mediastinal lymphadenopathy
HP:0001824Weight loss
Occasional (29-5%)
HP:0003270Abdominal distention
HP:0031500Abdominal mass
HP:0011024Abnormality of the gastrointestinal tract
HP:0012735Cough
HP:0025066Decreased mean corpuscular volume
HP:0030157Flank pain
HP:0008940Generalized lymphadenopathy
HP:0000952Jaundice
HP:0002017Nausea and vomiting
Very rare (<4-1%)
HP:0012050Anasarca
HP:0002094Dyspnea
HP:0000790Hematuria
HP:0005214Intestinal obstruction
HP:0011974Myelofibrosis
HP:0000083Renal insufficiency
HP:0001723Restrictive cardiomyopathy
HP:0001873Thrombocytopenia
HP:0006000Ureteral obstruction

Run the differential on the 1 obligate / very frequent terms

Annotation source: 30598916[PMID]_30746379[PMID]_30680887[PMID]

7

Sources for this card